Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Gaingels

Data updated

401 Park Ave S., 10th FL., New York, NY 10016, United States

Gaingels is a venture investment syndicate and network that co-invests with venture capital leads across a wide range of sectors and stages, from pre-seed to pre-IPO. Its public materials describe it as an LGBTQIA+/allies investor network focused on diversity, inclusion, and access in venture. The organization’s mailing address is in New York, New York, United States.

Gaingels says it invests globally and supports venture-backed companies in any sector, with a notable emphasis on healthcare and biotech alongside other high-growth categories. In the psychedelic ecosystem, that makes it relevant as a potential co-investor for drug-development companies that fit its broader mental health and biotech orientation, even though its public portfolio page does not single out psychedelics as a dedicated focus.

Investor Context

Angel Investors

Investment Context

This stakeholder is listed as a Syndicate / Network within Angel Investors. Its public geography context is global. Public stage signals include Pre-Seed and Seed. Public focus areas include Drug Development.

Gaingels is best characterized as a large venture syndicate / network that does not lead rounds, but instead co-invests alongside established VCs in competitive rounds across sectors and stages. Public-facing materials emphasize inclusive leadership, LGBTQIA+ representation, and a broad portfolio spanning healthcare, biotech, AI, fintech, and more, with investments typically pooled through SPVs. Its psychedelic relevance appears indirect rather than explicit: it is a plausible co-investor for mental health and drug-development companies, but there is no public evidence here of a dedicated psychedelic thesis or named psychedelic investments.

Investor Type

Syndicate / Network

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

Pre-SeedSeed

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Syndicate / Network

Investment Website

Quick Facts

Founded
2014
HQ
401 Park Ave S., 10th FL., New York, NY 10016, United States
Website
Visit